STANDARD BIOTOOLS INC. — Director's Dealing 2024

Apr 6, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2024-04-04

Reporting Person: Kim Hanjoon Alex (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-04-04	Common Stock	M	70183	—	Acquired	140366	Direct
2024-04-05	Common Stock	A	70702	—	Acquired	211068	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-04	Restricted Stock Units	$	M	70183	Disposed		Common Stock (70183)	Direct

Footnotes

F1: On April 11, 2023, the Reporting Person was granted a target amount of 77,185 performance-based restricted stock units ("RSUs") under the Issuer's 2011 Equity Incentive Plan, as amended. Each RSU represent the right, upon achievement of certain pre-established performance criteria, to receive one share of the Issuer's common stock, subject to vesting conditions. On April 5, 2024, the Board of Directors of the Issuer determined that certain of the RSU performance-based conditions were met resulting in the vesting of 70,702 RSUs as of March 31, 2024.

F2: Each RSU represents the contingent right to receive one share of the Issuer's common stock.

F3: On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023.